Closer to home I'd suggest you read the announcement yesterday from Telix pharma (TLX), regarding their prostate cancer trial using rADC.
This is the path Cheryl has identified going forward, question is how much catch up is there to be done? TLX already through phases 1 and 2 with data from 240 plus patients.
What role for DEP in future?
- Forums
- ASX - By Stock
- New indications for irinotecan
Closer to home I'd suggest you read the announcement yesterday...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.90M |
Open | High | Low | Value | Volume |
9.5¢ | 9.8¢ | 9.5¢ | $3.089K | 31.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 58131 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 34876 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 58131 | 0.096 |
3 | 308325 | 0.095 |
4 | 360000 | 0.094 |
2 | 9659 | 0.093 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 34876 | 2 |
0.105 | 209291 | 3 |
0.110 | 168286 | 9 |
0.115 | 85453 | 2 |
0.120 | 79405 | 9 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |